SBIR/STTR Research Award

Polarization Sensitive OCT for Imaging Caries Lesions

Award identifier 313fa5ecff7ec5ade6ad119afedc18ee6542a20ebeb132815540f09cf1da87c3Awarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$97,972

Program and phase

SBIR · Phase I

Award year

2005

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
Optiphase, Inc.
Proposal award date
Not reported
Contract end date
Not reported
UEI
E3FJG8P958A6
Solicitation number
PHS2005-2
Topic code
Not reported

Research abstract

DESCRIPTION (provided by applicant): The overall objective of the proposed research is to develop a low cost Polarization-Sensitive Optical Coherence tomography (PS-OCT) system for the early detection, diagnosis and monitoring of dental caries. New, more sophisticated diagnostic tools are needed so that if such carious lesions are detected early enough, they can be arrested/reversed by non-surgical means through fluoride therapy, anti-bacterial therapy, dietary changes, or by low intensity laser irradiation. Recent studies indicate that polarization sensitivity is necessary in order to quantify the severity of the caries lesions in occlusal and inter-proximal surfaces. Current PS-OCT designs are prohibitively expensive to manufacture and do not satisfy clinical use cost objectives. This Phase I proposal outlines a new and innovative PS-OCT design approach which shows substantial promise at meeting such cost objectives. It replaces the traditional Michelson design with an auto-correlator adapted with a novel polarization switching probe. The objectives of Phase I will be achieved through the following two specific aims. Aim 1 is the development and fabrication of a prototype PS-OCT system embodying the proposed design approach. Aim 2 is to demonstrate through in-vitro imaging with extracted human teeth that the prototype system has the requisite performance for monitoring the progression of tooth decay. A successful Phase I will lead to a Phase II effort which will focus on the design and development of a PS-OCT instrument and hand held probe suitable for in-vivo clinical evaluations. The Phase II objectives are: 1) The design provide high resolution imaging of incipient caries; 2) It can be transitioned to a manufacturing process meeting the cost objectives of market-wide acceptance in the dental field; and 3) The design is suitable to our already selected Phase III partner. Other commercial applications include medical imaging of oral cancer and pre-cancers, bi-refringent tissues and non-destructive evaluation of materials, laminations and composite structures.

Technology keywords

Not reported

Other awards by this recipient

Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.

Research funding history

21 SBIR/STTR records share this UEI (1991–2012). Reported award amounts total $3,775,847. Reported amounts are not federal obligations.

Phases: Phase I, Phase II

Agencies: Department of Defense, Department of Commerce, National Aeronautics and Space Administration, Department of Energy, Department of Health and Human Services

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.